One month after the third dose ( 7 months of age ) , the geometric mean concentration of antibody to hepatitis B surface antigen was approximately 3.5-fold higher in Group 2 than in Group 1 infants ( 3643 and 1052 mIU/ml , respectively ; < 0.001 ) .
